Company Filing History:
Years Active: 2025
Title: Hervé Balusson: Innovator in Algal Extracts for Immunosuppression Treatment
Introduction
Hervé Balusson is a notable inventor based in Bréhan, France. He has made significant contributions to the field of immunology through his innovative work with algal extracts. His research focuses on the treatment and prevention of post-traumatic immunosuppression, showcasing his commitment to advancing medical science.
Latest Patents
Hervé Balusson holds a patent for an "Algal extract for use in the treatment or prevention of post-traumatic immunosuppression." This patent discloses an extract of algae from the order Ulvales, which includes sulfated and non-sulfated polyanionic polysaccharides. The molecular weight of these extracts is less than or equal to 50 kDa, making them suitable for preventing and treating complications associated with post-traumatic immunosuppression. He has 1 patent to his name.
Career Highlights
Throughout his career, Hervé has worked with various companies, including Amadeite and Olmix. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in the use of natural extracts in medical applications.
Collaborations
Hervé Balusson has collaborated with notable professionals in his field, including Karim Asehnoune and Cédric Jacqueline. These partnerships have further enriched his research and development efforts, leading to impactful innovations.
Conclusion
Hervé Balusson is a distinguished inventor whose work with algal extracts has the potential to transform the treatment of post-traumatic immunosuppression. His contributions to science and collaboration with other experts highlight the importance of innovation in addressing medical challenges.